Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Catherine K Yeung

Showing results (1-10 of 43) with videos related to

Pageof 5
Sort By:
Clinical Journal of the American Society of Nephrology : CJASN|October 3, 2018
Kidneys on Chips: Emerging Technology for Preclinical Drug DevelopmentCatherine K Yeung, Jonathan Himmelfarb
Methods in Molecular Biology (Clifton, N.J.)|May 25, 2006
Benzydamine N-oxygenation as a measure of flavin-containing monooxygenase activityCatherine K Yeung, Allan E Rettie
Methods in Molecular Biology (Clifton, N.J.)|May 25, 2006
Prochiral sulfoxidation as a probe for flavin-containing monooxygenasesCatherine K Yeung, Allan E Rettie
Archives of Biochemistry and Biophysics|May 29, 2007
Functional characterization of genetic variants of human FMO3 associated with trimethylaminuriaCatherine K Yeung, Elinor T Adman, Allan E Rettie
Current Opinion in Toxicology|May 2, 2022
Kidney microphysiological models for nephrotoxicity assessmentAnish Mahadeo, Catherine K Yeung, Jonathan Himmelfarb, et al.
Chemical Research in Toxicology|February 17, 2009
Qualitative analysis of the role of metabolites in inhibitory drug-drug interactions: literature evaluation based on the metabolism and transport drug interaction databaseNina Isoherranen, Houda Hachad, Catherine K Yeung, et al.
Biochimica Et Biophysica Acta|May 24, 2008
Physical, kinetic and spectrophotometric studies of a NAD(P)-dependent benzaldehyde dehydrogenase from Pseudomonas putida ATCC 12633Catherine K Yeung, Alejandra Yep, George L Kenyon, et al.
Kidney International|October 18, 2013
Effects of chronic kidney disease and uremia on hepatic drug metabolism and transportCatherine K Yeung, Danny D Shen, Kenneth E Thummel, et al.
Clinical and Translational Science|November 3, 2023
Predicting complex kidney drug handling using a physiologically-based pharmacokinetic model informed by biomarker-estimated secretory clearance and blood flowMichael L Granda, Weize Huang, Catherine K Yeung, et al.
Pediatric Research|January 26, 2002
Human hepatic flavin-containing monooxygenases 1 (FMO1) and 3 (FMO3) developmental expressionSevasti B Koukouritaki, Pippa Simpson, Catherine K Yeung, et al.
Pageof 5

Showing results (1-10 of 43) with videos related to

Sort By:
Pageof 5
Clinical Journal of the American Society of Nephrology : CJASN|October 3, 2018
Kidneys on Chips: Emerging Technology for Preclinical Drug DevelopmentCatherine K Yeung, Jonathan Himmelfarb
Methods in Molecular Biology (Clifton, N.J.)|May 25, 2006
Benzydamine N-oxygenation as a measure of flavin-containing monooxygenase activityCatherine K Yeung, Allan E Rettie
Methods in Molecular Biology (Clifton, N.J.)|May 25, 2006
Prochiral sulfoxidation as a probe for flavin-containing monooxygenasesCatherine K Yeung, Allan E Rettie
Archives of Biochemistry and Biophysics|May 29, 2007
Functional characterization of genetic variants of human FMO3 associated with trimethylaminuriaCatherine K Yeung, Elinor T Adman, Allan E Rettie
Current Opinion in Toxicology|May 2, 2022
Kidney microphysiological models for nephrotoxicity assessmentAnish Mahadeo, Catherine K Yeung, Jonathan Himmelfarb, et al.
Chemical Research in Toxicology|February 17, 2009
Qualitative analysis of the role of metabolites in inhibitory drug-drug interactions: literature evaluation based on the metabolism and transport drug interaction databaseNina Isoherranen, Houda Hachad, Catherine K Yeung, et al.
Biochimica Et Biophysica Acta|May 24, 2008
Physical, kinetic and spectrophotometric studies of a NAD(P)-dependent benzaldehyde dehydrogenase from Pseudomonas putida ATCC 12633Catherine K Yeung, Alejandra Yep, George L Kenyon, et al.
Kidney International|October 18, 2013
Effects of chronic kidney disease and uremia on hepatic drug metabolism and transportCatherine K Yeung, Danny D Shen, Kenneth E Thummel, et al.
Clinical and Translational Science|November 3, 2023
Predicting complex kidney drug handling using a physiologically-based pharmacokinetic model informed by biomarker-estimated secretory clearance and blood flowMichael L Granda, Weize Huang, Catherine K Yeung, et al.
Pediatric Research|January 26, 2002
Human hepatic flavin-containing monooxygenases 1 (FMO1) and 3 (FMO3) developmental expressionSevasti B Koukouritaki, Pippa Simpson, Catherine K Yeung, et al.
Pageof 5